Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.
Quick Stats
Jun 23, 202660.6
AI Score
BUY1.59
Volume Ratio
Aug 05, 2026
Next Earnings
14
+ve Days (30d)
16
-ve Days (30d)
IMNM Stock Summary
Last updated Jun 23, 2026
IMNM is currently trading at $19.33, positioned below its 200-day moving average of $19.42, suggesting bearish momentum. The stock has a 52-week range of $7.96 to $27.65.
Technical Analysis: The 50-day moving average stands at $21.44, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 46.061, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.178, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates IMNM at 60.6/100 with a BUY recommendation.
IMNM (Immunome, Inc.) Indicators
Last updated Jun 23, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 46.061 |
| CMF (20) | -0.178 |
| ROC (10) | 3.869 |
| ADX (14) | 18.516 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -0.755 |
| AROONOSC (14) | -71.429 |
| WILLAMS %R (14) | -37.5 |
| MFI (14) | 54.741 |
IMNM Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
IMNM Price vs Max Options Open Interest
IMNM Max Change In Options Open Interest
IMNM Options - Sort by Max open Interest (near term)
24th June 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
IMNM Daily Out of Money Options - Sort by Max open Interest (near term)
24th June 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
IMNM Daily In the Money Options - Sort by Max open Interest (near term)
24th June 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
IMNM Most Active Options by Volume(near term)
24th June 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Immunome, Inc. is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
IMNM Moving Averages Analysis
IMNM (Immunome, Inc.) Simple Moving Averages
Moving Averages are last updated Jun 23, 2026
| Days | MA |
|---|---|
| 10 | 18.51 |
| 20 | 19.51 |
| 30 | 20.22 |
| 50 | 21.44 |
| 100 | 21.78 |
| 200 | 19.42 |
IMNM Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 2.2 billion |
| Earnings/Share ($) | -2.39 |
| Net Proft Margin (%) | 0 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -2.1247 |
| EPS Estimate Next Year ($) | -2.0968 |
| WallStreet Target Price ($) | 35.7692 |
| Most Recent Quarter |